Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin- releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: Evidence from GnRH agonist and human chorionic gonadotropin stimulation testing

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 4103-4107

  Ibañez, Lourdes ^a,d   Hall, Janet E ^c   Potau, Neus ^a   Carrascosa, A ^a   Prat, Neus ^b   Taylor, Ann E ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE VILADECANS   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CYTOCHROME P450; GONADORELIN; GONADORELIN AGONIST; HYDROXYPROGESTERONE; LEUPRORELIN; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HYPERANDROGENISM; LUTEINIZING HORMONE RELEASE; OLIGOMENORRHEA; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 0029798428     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.4103     Document Type: Article

References (31)

1. Zawadzki JK, Dunaif A. 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Boston: Blackwell; 377-384.
2. Hall JE. 1993 Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis. Endocrinol Metab Clin North Am. 22:75-92.
3. Barnes RB, Rosenfield RL. 1989 Polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 110:386-399.
4. Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. 1989 Pituitary-ovarian responses to nafarelin in the polycystic ovary syndrome. N Engl J Med. 320:559-565.
5. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. 1990 Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil Steril. 53:785-790.
6. Ibañez L, Potau N, Zampolli M, et al. 1994 Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab. 79:1778-1784.
7. Ibañez L, Potau N, Virdis R, et al. 1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1599-1603.
8. Crowley Jr WF, Beitins IZ, Vale W, et al. 1980 The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. N Engl J Med. 302:1052-1057.
9. Rosenfield RL, Burstein S, Cuttler L, et al. 1989 Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 34:(Suppl):1044-1050.
10. O'Dea LSL, Finkelstein JS, Schoenfeld DA, Butler JP, Crowley Jr WF. 1989 Interpulse interval of GnRH stimulation independently modulates LH secretion. Am J Physiol. 256:E510-E515.
11. Rebar R, Judd HL, Yen SSC, Rakoff J, Vanderburg G, Naftolin F. 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 57:1320-1329.
12. New MI, Lorenzen F, Lerner AJ, et al. 1983 Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 56:3320-3325.
13. Pang S, Lerner AJ, Stoner E, et al. 1985 Late-onset steroid 3β-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab. 60:428-439.
14. Ferriman D, Gallway JD. 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 21:1440-1447.
15. Levrant SG, Barnes RB, Rosenfield RL. hCG-stimulated 17,20 lyase activity is unaffected by tamoxifen in PCOS or normal subjects [Abstract 837]. Proc of the 76th Annual Meet of The Endocrine Soc. 1994.
16. Filicori M, Butler JP, Crowley Jr WF. 1984 Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest. 73:1638-1647.
17. Taylor AE, Khoury RH, Crowley Jr WF. 1994 A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation. J Clin Endocrinol Metab. 79:240-247.
18. Rosenfield RL, Barnes RB, Ehrmann DA. 1994 Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 79:1686-1692.
19. Dunkel L, Perheentupa J, Sorva R. 1985 Single versus repeated dose human chorionic gonadotropin stimulation in the differential diagnosis of hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 60:333-337.
20. Martikainen H, Huhtaniemi I, Vihko R. 1980 Response of peripheral sex steroids and some of their precursors to a single injection of hCG in adult men. Clin Endocrinol (Oxf). 13:157-166.
21. Forest M, Saez JM, Bertrand J. 1973 Assessment of gonadal function in children. Paediatrician. 2:102-128.
22. Rosenfield RL, Ehrlich EN, Cleary R. 1972 Adrenal and ovarian contributions to the elevated plasma free androgen levels in hirsute women. J Clin Endocrinol Metab. 34:92-98.
23. Ehrmann DA, Barnes RB, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:322-353.
24. Gilling-Smith C, Willis DS, Beard RW, Franks S. 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 79:1158-1165.
25. Dufau ML, Cigorraga S, Baukal AJ, et al. 1979 Androgen biosynthesis in Leydig cells after testicular desensitization by luteinizing hormone-releasing hormone and human chorionic gonadotropin. Endocrinology. 105:1314-1321.
26. Cigorraga SB, Sorell S, Bator J, Catt KJ, Dufau ML. 1980 Estrogen dependence of a gonadotropin-induced steroidogenic lesion in rat testicular Leydig cells. J Clin Invest. 65:699-705.
27. Nozu K, Matsura S, Catt KJ, Dufau ML. 1981 Modulation of Leydig cell androgen biosynthesis and cytochrome P-450 levels during estrogen treatment and human chorionic gonadotropin-induced desensitization. J Biol Chem. 256:10012-10017.
28. Nozu K, Dufau ML, Catt KJ. 1981 Estradiol receptor-mediated regulation of steroidogenesis in gonadotropin-desensitized Leydig cells. J Biol Chem. 256:1915-1922.
29. Nozu K, Dehejia A, Zawistowich L, Catt KJ, Dufau ML. 1982 Gonadotropin-induced desensitization of Leydig cells in vivo and in vitro: estrogen action in the testis. Ann NY Acad Sci. 383:212-230.
30. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157-162.
31. Ryan K. 1979 Granulosa-thecal cell interaction in ovarian steroidogenesis. J Steroid Biochem. 11:799-800.